AbCellera Biologics Inc.

2.31
-0.05 (-2.12%)
At close: Mar 28, 2025, 3:59 PM
2.30
-0.43%
After-hours: Mar 28, 2025, 06:19 PM EDT

AbCellera Biologics Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
Revenue 28.83M 38.02M 485.42M 375.2M 233.16M 11.61M 8.83M
Cost of Revenue n/a n/a 66.44M 45.52M 27.14M 10.11M 5.8M
Gross Profit 28.83M 38.02M 418.99M 329.69M 206.01M 1.5M 3.03M
Operating Income -314.77M -237.21M 216.51M 204.41M 156.03M -4.12M -753K
Interest Income 38.47M 42.25M 16.08M 3.33M 293K 154.96K 42K
Pretax Income -200.4M -174.03M 239.1M 219.15M 157.83M -2.21M 309K
Net Income -162.86M -146.4M 158.52M 153.46M 118.92M -2.42M 309K
Selling & General & Admin 85.49M 75.18M 66.75M 48.76M 15.75M 4.01M 2.86M
Research & Development 167.26M 175.66M 107.88M 62.06M 29.39M 10.11M 5.8M
Other Expenses 90.85M 24.39M 17.29M -3.04M -3.48M -170.41K -675.51K
Operating Expenses 343.6M 275.23M 191.92M 107.79M 41.66M 13.95M 7.99M
Interest Expense n/a n/a 4.04M 5.22M 6.51M 209.2K 212K
Selling & Marketing Expenses 12.78M 14.18M 11.27M 6.91M 3.84M 1.26M 712K
Cost & Expenses 343.6M 275.23M 258.36M 153.3M 68.8M 13.95M 7.99M
Income Tax -37.54M -27.63M 80.58M 65.69M 38.91M 209.2K 1.27M
Shares Outstanding (Basic) 294.33M 289.17M 285.06M 275.76M 269.5M 154.09M 237.72M
Shares Outstanding (Diluted) 294.33M 289.17M 314.83M 318.29M 269.5M 154.09M 237.72M
EPS (Basic) -0.55 -0.51 0.56 0.56 0.44 -0.02 0.00
EPS (Diluted) -0.55 -0.51 0.50 0.48 0.44 -0.02 0.00
EBITDA -204.15M -192.16M 272.2M 241.62M 169.62M -397.42K 165K
Depreciation & Amortization 97M 30.89M 33.1M 17.25M 5.27M 1.6M 918.46K